Researchers at the University of Texas Health Science Center at San Antonio have identified a mechanism behind bone strengthening in response to ...
News
- Potential New Targets for Treating Osteoporosis Revealed in Mouse Study
- Mevion Selected to Equip New Proton Therapy and Research Center in San Antonio | BioSpace
It will be the first proton therapy system in San Antonio and South Texas ... dentistry, health professions and graduate biomedical sciences have ...
- FDA's agenda in limbo as Biden's nominee stalls in Senate | WOAI
Califf has recently served as a board director or adviser to more than a half-dozen drug and biotech companies, according to his ethics disclosure ...
- INVO Bioscience Eyes +20 U.S. Cities To Expand Rollout Of Advanced Infertility Treatment ...
INVO Bioscience (NASDAQ:INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® ...
- Seattle Genetics: Q4 Earnings Snapshot - San Antonio Express-News
The biotechnology company posted revenue of $429.9 million in the period, beating Street forecasts. Eight analysts surveyed by Zacks expected ...